Neurocrine Bioscience buy Barclays PLC
Start price
02.08.24
/
50%
€139.00
Target price
02.08.25
€164.74
Performance (%)
-22.88%
Price
19:09
€107.20
Summary
This prediction is currently active. The prediction for Neurocrine Bioscience disappoints with a performance of -22.88%. This prediction currently runs until 02.08.25. The prediction end date can be changed by Barclays_PLC at any time. Barclays_PLC has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m |
---|---|---|
Neurocrine Bioscience | -6.936% | -6.936% |
iShares Core DAX® | -2.385% | 3.986% |
iShares Nasdaq 100 | -4.527% | -0.258% |
iShares Nikkei 225® | -4.129% | 4.382% |
iShares S&P 500 | -2.885% | 1.387% |
Comments by Barclays_PLC for this prediction
In the thread Neurocrine Bioscience diskutieren
Neurocrine Biosciences, Inc. (NASDAQ: NBIX) had its price target raised by analysts at Barclays PLC from $169.00 to $180.00. They now have an "overweight" rating on the stock.
Ratings data for NBIX provided by MarketBeat
Stopped prediction by Barclays_PLC for Neurocrine Bioscience
Neurocrine Bioscience
Start price
Target price
Perf. (%)
€109.95
09.09.24
09.09.24
€144.91
09.09.25
09.09.25
-0.96%
19:09
19:09
Neurocrine Bioscience
Start price
Target price
Perf. (%)
€131.25
02.05.24
02.05.24
€157.54
02.05.25
02.05.25
-17.03%
19:09
19:09
Neurocrine Bioscience
Start price
Target price
Perf. (%)
€129.15
23.01.24
23.01.24
€137.96
23.01.25
23.01.25
-15.68%
19:09
19:09